# CONSENSI
> **NDA210045** · New Drug Application · Sponsor: PURPLE BIOTECH · Approved 2018-05-31
## Drug
- **FDA Application Number:** NDA210045
- **Application type:** New Drug Application
- **Brand name:** CONSENSI
- **Generic name:** Amlodipine Besylate
- **Active ingredients:** AMLODIPINE BESYLATE; CELECOXIB
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** PURPLE BIOTECH
- **First approval:** 2018-05-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210045)
---
*AI Analytics · CC0 1.0*